Vairaktaris, E <br/><br/>
Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer.  [electronic resource] 

 -  Oral oncology  Oct 2006 
 - 888-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1368-8375 
<br/><br/><label>Standard No.: </label>10.1016/j.oraloncology.2005.12.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Distribution<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Squamous Cell--genetics<br/>Case-Control Studies<br/>Female<br/>Gene Frequency<br/>Genetic Predisposition to Disease<br/>Genotype<br/>Humans<br/>Male<br/>Middle Aged<br/>Mouth Neoplasms--genetics<br/>Neoplasm Staging<br/>Plasminogen Activator Inhibitor 1--genetics<br/>Polymorphism, Genetic<br/>Promoter Regions, Genetic<br/>Risk Factors